PIRAMAL PHARMA LIMITED (PPLPHARMA)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 1,748.85 1,911.38 1,958.57 2,552.36 1,951.14 2,241.75 2,204.22 2,754.07 1,933.71 2,043.72 2,139.87 2,751.77
YOY Revenue Growth % - 11.13% 14.14% 17.97% 11.57% 17.28% 12.54% 7.9% -0.89% -8.83% -2.92% -0.08%
Other Income 38.31 49.19 61.51 26.38 19.54 61.11 12.13 42.03 58.40 65.60 43.24 46.06
Total Income 1,787.16 1,960.57 2,020.08 2,578.74 1,970.68 2,302.86 2,216.35 2,796.10 1,992.11 2,109.32 2,183.11 2,797.83
Total Expenses + 1,407.20 1,539.73 1,642.68 1,408.12 1,543.76 1,678.81 1,866.09 2,539.52 2,110.44 2,170.29 2,246.12 2,592.63
Cost of Materials Consumed 417.40 531.72 627.63 400.08 471.48 575.14 805.44 203.68 524.35 483.42 505.48 482.59
Employee Benefit Expense 495.54 516.03 523.78 494.15 579.69 559.53 556.24 612.01 618.59 611.46 599.85 586.02
Other Expenses 494.27 491.98 491.27 513.89 492.59 544.14 504.41 626.09 514.37 571.07 557.98 649.57
Operating Profit 341.65 371.65 315.89 1,144.24 407.38 562.94 338.13 214.55 -176.73 -126.57 -106.25 159.14
OPM % 19.5% 19.4% 16.1% 44.8% 20.9% 25.1% 15.3% 7.8% -9.1% -6.2% -5% 5.8%
Profit Before Tax + -121.50 20.45 5.41 215.44 -67.48 102.86 49.75 256.58 -97.59 -60.97 -104.12 29.43
Tax Expense -22.91 15.43 -4.70 114.17 21.16 80.27 46.07 103.08 -15.89 38.25 32.07 38.25
Tax % - 75.5% -86.9% 53% - 78% 92.6% 40.2% - - - 130%
Profit After Tax -98.58 5.02 10.11 101.27 -88.64 22.59 3.68 153.50 -81.70 -99.22 -136.19 -8.82
EPS (Basic) -0.83 0.04 0.08 0.77 -0.67 0.17 0.03 1.16 -0.62 -0.75 -1.03 -0.07

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023
Revenue from Operations 9,151.18 8,171.16 7,081.55
YOY Revenue Growth % 11.99% 15.39% -
Other Income 134.81 175.39 225.11
Total Income 9,285.99 8,346.55 7,306.66
Total Expenses + 8,944.28 5,997.73 5,432.47
Cost of Materials Consumed 2,055.74 1,976.83 1,682.46
Employee Benefit Expense 2,307.47 2,029.50 1,896.35
Other Expenses 2,167.23 1,991.40 1,853.66
Operating Profit 206.90 2,173.43 1,649.08
OPM % 2.3% 26.6% 23.3%
Profit Before Exceptional 341.71 182.59 -167.52
Exceptional Items 0.00 -62.79 -6.96
Profit Before Tax + 341.71 119.80 -174.48
Tax Expense 250.58 101.98 11.98
Tax % 73.3% 85.1% -
Profit After Tax 91.13 17.82 -186.46
EPS (Basic) 0.69 0.14 -1.57

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023
ASSETS
Non-Current Assets + 9,880.60 9,847.34 9,687.08
Property, Plant & Equipment 4,175.98 3,872.64 3,363.04
Capital Work in Progress 489.12 565.70 852.93
Non-Current Investments 44.30 34.94 41.76
Goodwill 1,148.21 1,122.55 1,107.51
Other Intangible Assets 2,450.85 2,617.11 2,772.57
Current Assets + 5,796.99 5,464.47 4,835.48
Inventories 2,312.70 2,175.88 1,681.37
Trade Receivables 2,349.52 2,134.43 1,799.34
Cash and Cash Equivalents 368.98 356.82 195.59
Current Investments 19.56 144.69 427.11
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00
Equity Share Capital 1,324.35 1,322.95 1,193.32
Other Equity 6,801.12 6,588.42 5,580.18
Non-Current Liabilities 3,785.85 3,031.14 3,906.01
Current Liabilities 3,766.27 4,369.30 3,843.05
Total Liabilities 7,552.12 7,400.44 7,749.06

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023
Cash from Operating Activities 892.30 1,004.54 483.89
Cash from Investing Activities -477.46 -434.01 -1,338.78
Cash from Financing Activities -440.83 -422.36 817.79
Net Increase/Decrease in Cash -36.87 165.96 -31.95